advertisement
Harasymowycz P 8
Showing records 1 to 8 | Display all abstracts from Harasymowycz P92073 Three-Year Outcomes of Second-generation Trabecular Micro-bypass Stents (iStent inject) With Phacoemulsification in Various Glaucoma Subtypes and Severities
Salimi A
Journal of Glaucoma 2021; 30: 266-275
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Harasymowycz P
Advances in Therapy 2021; 38: 3019-3031
92073 Three-Year Outcomes of Second-generation Trabecular Micro-bypass Stents (iStent inject) With Phacoemulsification in Various Glaucoma Subtypes and Severities
Salimi A; Salimi A
Journal of Glaucoma 2021; 30: 266-275
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Hutnik C
Advances in Therapy 2021; 38: 3019-3031
92073 Three-Year Outcomes of Second-generation Trabecular Micro-bypass Stents (iStent inject) With Phacoemulsification in Various Glaucoma Subtypes and Severities
Watt H
Journal of Glaucoma 2021; 30: 266-275
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Rouland JF
Advances in Therapy 2021; 38: 3019-3031
92073 Three-Year Outcomes of Second-generation Trabecular Micro-bypass Stents (iStent inject) With Phacoemulsification in Various Glaucoma Subtypes and Severities
Harasymowycz P
Journal of Glaucoma 2021; 30: 266-275
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Negrete FJM; Economou MA; Denis P; Baudouin C
Advances in Therapy 2021; 38: 3019-3031
